These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 31848078)

  • 21. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
    Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
    Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.
    Harder J; Müller MJ; Fuchs M; Gumpp V; Schmitt-Graeff A; Fischer R; Frank M; Opitz O; Hasskarl J
    World J Gastroenterol; 2013 Dec; 19(48):9334-42. PubMed ID: 24409060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
    Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
    BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
    Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
    [No Abstract]   [Full Text] [Related]  

  • 27. Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status.
    Moriwaki T; Ishige K; Araki M; Yoshida S; Nishi M; Sato M; Yamada T; Yamamoto Y; Ozeki M; Ishida H; Yamaguchi T; Matsuda K; Murashita T; Abei M; Hyodo I
    Med Oncol; 2014 Nov; 31(11):287. PubMed ID: 25316268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma.
    Oshiro Y; Sasaki R; Fukunaga K; Kondo T; Oda T; Takahashi H; Ohkohchi N
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):389-95. PubMed ID: 23138964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study.
    Utsumi M; Kitada K; Tokunaga N; Kato T; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    BMC Gastroenterol; 2021 Oct; 21(1):375. PubMed ID: 34645392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma.
    Lee W; Jeong CY; Jang JY; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Ryu JH; Yang K; Choi CS; Park YH; Nah YW; Kim R; Navarro J; Han DH; Choi GH; Kang CM; Kim KS; Hong SC
    Eur J Surg Oncol; 2020 May; 46(5):832-838. PubMed ID: 31806519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
    Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors.
    Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA
    Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
    Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
    Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.